Although it can be argued that peptides with amino acid changes at anchor positions may be more immunogenic as a result of lack of central tolerance, the majority of the 65 HLA class I-restricted MiHA that have been identified as in vivo T-cell targets in anti-tumor responses after alloSCT contain amino acid changes at TCR contact residues. The gene discussed is XIAP; the disease is neoplasm.